71 results
DEFA14A
TRML
Tourmaline Bio Inc
19 Apr 24
Additional proxy soliciting materials
4:04pm
Additional Materials
☐ Soliciting Material Pursuant to §240.14a-12
Tourmaline Bio, Inc.
(Name of Registrant as Specified In Its Charter)
N/A
(Name … previously with preliminary materials.
☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
Materials” means any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing … ); and “Permitted Section 5(d) Communication” means the Section 5(d) Written Communication(s) and Marketing Materials listed on Schedule C attached
8-K
EX-99.1
6hkctz7ltz
24 Jan 24
Results of Operations and Financial Condition
5:10pm
8-K
EX-10.1
r6ark
27 Oct 23
Departure of Directors or Certain Officers
5:17pm
425
sn5svk 78ti0je
10 Oct 23
Business combination disclosure
4:32pm
8-K/A
vpd66u3muxviub ht
10 Oct 23
Other Events
4:30pm
425
llerd5
10 Oct 23
Business combination disclosure
12:00am
8-K
klhqbf
6 Oct 23
Talaris Therapeutics Declares Special Dividend
5:30pm
8-K
EX-99.1
xh1jdyw8d03lt
6 Oct 23
Talaris Therapeutics Declares Special Dividend
5:30pm
425
00tj2ouqm 6pxmlx8pvt
6 Oct 23
Business combination disclosure
5:27pm
8-K
wo3dne21s5r5q0j
6 Oct 23
Other Events
5:26pm
425
0uueokrg
26 Sep 23
Business combination disclosure
8:24am
8-K
zbgg19tchnzvypl
26 Sep 23
Regulation FD Disclosure
8:21am
8-K
EX-99.1
ofihl j16a44m
26 Sep 23
Regulation FD Disclosure
8:21am
424B3
12memuqd
15 Sep 23
Prospectus supplement
6:31am